4
Changes in Ownership
Stoke Therapeutics, Inc. Filed Acc 0001522780-25-000004
Director sold 42,461 shares at $25.09 ($1,065,206)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Kaye Edward M. MD · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-10-03 | Sale : show line 1 in the form 10b5-1 | −42,461 | $25.09 | $1,065,206 | 49,124 | D |
| Open-market sales · 42,461 sh · avg $25.09 · $1,065,206 | ||||||
Loading xslF345X05/form4-10072025_081055.xml…